Correlation Between Vytrus Biotech and Realia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vytrus Biotech and Realia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vytrus Biotech and Realia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vytrus Biotech SA and Realia, you can compare the effects of market volatilities on Vytrus Biotech and Realia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vytrus Biotech with a short position of Realia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vytrus Biotech and Realia.

Diversification Opportunities for Vytrus Biotech and Realia

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Vytrus and Realia is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Vytrus Biotech SA and Realia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Realia and Vytrus Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vytrus Biotech SA are associated (or correlated) with Realia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Realia has no effect on the direction of Vytrus Biotech i.e., Vytrus Biotech and Realia go up and down completely randomly.

Pair Corralation between Vytrus Biotech and Realia

Assuming the 90 days trading horizon Vytrus Biotech SA is expected to generate 4.65 times more return on investment than Realia. However, Vytrus Biotech is 4.65 times more volatile than Realia. It trades about 0.01 of its potential returns per unit of risk. Realia is currently generating about 0.01 per unit of risk. If you would invest  332.00  in Vytrus Biotech SA on September 3, 2024 and sell it today you would lose (116.00) from holding Vytrus Biotech SA or give up 34.94% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy92.87%
ValuesDaily Returns

Vytrus Biotech SA  vs.  Realia

 Performance 
       Timeline  
Vytrus Biotech SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vytrus Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Realia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Realia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Realia is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Vytrus Biotech and Realia Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vytrus Biotech and Realia

The main advantage of trading using opposite Vytrus Biotech and Realia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vytrus Biotech position performs unexpectedly, Realia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Realia will offset losses from the drop in Realia's long position.
The idea behind Vytrus Biotech SA and Realia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets